Connection

Hong Yu to Osteoclasts

This is a "connection" page, showing publications Hong Yu has written about Osteoclasts.
Connection Strength

1.395
  1. Sphingosine-1-Phosphate Receptor 2 Regulates Proinflammatory Cytokine Production and Osteoclastogenesis. PLoS One. 2016; 11(5):e0156303.
    View in: PubMed
    Score: 0.517
  2. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans. Lipids Health Dis. 2015 Jul 04; 14:66.
    View in: PubMed
    Score: 0.486
  3. Critical role of MKP-1 in lipopolysaccharide-induced osteoclast formation through CXCL1 and CXCL2. Cytokine. 2015 Jan; 71(1):71-80.
    View in: PubMed
    Score: 0.115
  4. Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease. J Periodontal Res. 2014 Aug; 49(4):518-26.
    View in: PubMed
    Score: 0.108
  5. Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss. Gene Ther. 2011 Apr; 18(4):344-53.
    View in: PubMed
    Score: 0.088
  6. Metabolic syndrome exacerbates inflammation and bone loss in periodontitis. J Dent Res. 2015 Feb; 94(2):362-70.
    View in: PubMed
    Score: 0.029
  7. Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome. J Dent Res. 2014 Mar; 93(3):294-9.
    View in: PubMed
    Score: 0.027
  8. Sustained mitogen-activated protein kinase activation with Aggregatibacter actinomycetemcomitans causes inflammatory bone loss. Mol Oral Microbiol. 2012 Oct; 27(5):397-407.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.